Italia markets open in 1 hour 59 minutes
Dow Jones
38.589,16 -57,94 (-0,15%) Nasdaq
17.688,88 +21,28 (+0,12%) Nikkei 225
37.977,18 -837,38 (-2,16%) EUR/USD
1,0708 -0,0001 (-0,01%) Bitcoin EUR
62.029,32 +245,42 (+0,40%) CMC Crypto 200
1.406,10 -11,77 (-0,83%)
ARCA biopharma, Inc. (ABIO)
NasdaqCM - NasdaqCM Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Dopo ore:
| Chiusura precedente | 3,3500 |
| Aperto | 3,2750 |
| Denaro | 3,2200 x 100 |
| Domanda | 3,3500 x 100 |
| Min-Max giorno | 3,1100 - 3,3100 |
| Intervallo di 52 settimane | 1,5600 - 4,4900 |
| Volume | |
| Media Volume | 1.459.452 |
| Capitalizzazione | 48,019M |
| Beta (mensile su 5 anni) | 0,96 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,4200 |
| Prossima data utili | 19 lug 2024 - 23 lug 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireARCA biopharma Announces Second Quarter 2023 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter 2023 financial results and provided a corporate update. In April 2022, the Board of Di
© 2024 Yahoo. Tutti i diritti riservati.